期刊文献+

干细胞因子与消化系统疾病的关系

下载PDF
导出
摘要 干细胞因子(stem cell factor,SCF)是一种具有广泛生物活性的细胞因子,是酪氨酸激酶C-Kit的配体。SCF最初仅作为早期造血细胞的调节因子被研究,随着研究技术的改进和研究内容的深入,发现SCF不仅对造血功能有重要的调节作用,而且还在许多组织中表达,并发挥广泛的生物学作用,目前SCF的生物学作用正被深入广泛地研究。该文重点介绍SCF与消化系统疾病的关系。
作者 程梅 王继红
出处 《生命的化学》 CAS CSCD 北大核心 2007年第6期562-564,共3页 Chemistry of Life
基金 重庆医科大学创新基金(No.CX200528)
  • 相关文献

参考文献18

  • 1Chabot B et al. Nature, 1988, 335:88 -89
  • 2Zsebo KM et al. Cell, 1990, 63(2): 195-201
  • 3Williams DE et al. Cell, 1990, 63(2): 167-174
  • 4Huang E et al. Cell, 1990, 63(2): 225-233
  • 5Battaglia E et al. World J Gastroenterol, 2006, 12(38): 6172- 6177
  • 6Ward SM et al. Am J Physiol, 2001, 281:G602-611
  • 7Mitsui R et al. Anat Embryol, 2003, 206:453-460
  • 8Nano M et al. Ann Surg Oncol, 2003, 10(7): 801-809
  • 9He CL et al. Gastroenterology, 2001, 121(2): 427-434
  • 10Horvath VJ et al. Gastroenterology, 2006, 130(3): 759- 770

二级参考文献58

  • 1李秀金,杨焕星,王晓茜,唐南洪,陈燕凌.原发性肝癌C-kit和SCF基因的表达及意义[J].临床肝胆病杂志,2005,21(2):108-109. 被引量:3
  • 2Yarden Y,Kuang WJ,Yang-Feng T,et al.Human proto-oncogene C-kit:a new cell surface receptor tyrosine kinase for an unidentified ligand.EMBO J,1987,6:3341-3351.
  • 3Lasota J,Jasinski M,Sarlomo-Rikala M,et al.Mutations in exon 11 of C-kit occur preferentially in malignant versus benign gastrointesinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas.Am J Pathol,1999,154::53-60.
  • 4Hirota S,Isozaki K,Moriyama Y,et al.Gain-of-function mutations of C-kit in human gastrointestinal stromal tumors.Science,1998,279::577-580.
  • 5Duarte RF,Frank DA.SCF and G-CSF lead to the synergistic induction of proliferation and gene expression through complementary signaling pathways.Blood,2000,96:3422-3430.
  • 6Tuveson DA,Willis NA,Jacks T,et al.STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein:biological and clinical implications.Oncogene,2001,20:5054-5058.
  • 7Yamamoto T,Nakatani T,Marui T,et al.Expression of stem cell factor and lack of c-kit expression in malignant fibrous histiocytoma of soft tissues.Anticancer Res,2003,23:4305-4308.
  • 8Potti A,Moazzam N,Ramar K,et al.CD117 (c-KIT) overexpression in patients with extensive-stage small-cell lung carcinoma.Ann Oncol,2003,14:894-897.
  • 9Tamborini E,Papini D,Mezzelani A,et al.c-KIT and c-KIT ligand (SCF) in synovial sarcoma (SS):an mRNA expression anal ysis in 23 cases.Br J Cancer,2001,85:405-411.
  • 10HEINRICH MC, BLANKE CD,DRUKER BJ,et al. Inhibition of kit tyrosine kinase activity: a novel molecular approach to the treatment of kit-positive malignancies[J]. J Clin Oncol,2002,20(6) : 1692-1703.

共引文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部